{"id":11541,"date":"2022-07-01T20:44:12","date_gmt":"2022-07-02T00:44:12","guid":{"rendered":"https:\/\/www.cancerresearch.org\/event\/cancer-immunotherapy-2022-research-and-a-look-ahead-with-e-john-wherry-ph-d\/"},"modified":"2023-04-20T15:39:23","modified_gmt":"2023-04-20T19:39:23","slug":"cancer-immunotherapy-2022-research-john-wherry","status":"publish","type":"cri_events","link":"https:\/\/www.cancerresearch.org\/es\/events\/cancer-immunotherapy-2022-research-john-wherry","title":{"rendered":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0"},"content":{"rendered":"\n<p>In this informative CRI webinar, prolific cancer immunotherapy expert E. John Wherry, PhD, discusses promising new research and treatments in the year ahead. Dr. Wherry breaks down recently developed treatment strategies in patient care, what biomarkers are and how they can inform a treatment plan, and the latest discoveries in cellular immunotherapy for solid tumors. Dr. Wherry is the director of the Institute for Immunology, the chair of the Department of Systems Pharmacology and Translational Therapeutics, and the Richard and Barbara Schiffrin President\u2019s Distinguished Professor at the University of Pennsylvania Perelman School of Medicine. Additionally, he is an associate director of CRI&#8217;s Scientific Advisory Council. Researchers have cited his work almost 50,000 times in peer-reviewed publications and he has authored more than 200 papers.<\/p>\n\n\n\n\n\n<figure class=\"wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio\"><div class=\"wp-block-embed__wrapper\">\n<iframe loading=\"lazy\" title=\"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, Ph.D.\" width=\"500\" height=\"281\" src=\"https:\/\/www.youtube.com\/embed\/_ltam5Gs5Ys?feature=oembed\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe>\n<\/div><\/figure>\n\n\n\n<p>Funding for the CRI \u00abCancer Immunotherapy and You\u00bb webinar series is generously provided by Bristol Myers Squibb as well as Alkermes and Lilly Oncology.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dr. E. John Wherry&nbsp;discusses what might lie ahead for the field in 2022&mdash;and what it means for patients.<\/p>\n","protected":false},"featured_media":27531,"template":"","events_categories":[421],"resource_cancer_types":[],"resource_patient_age":[],"resource_cancer_stage":[],"resource_treatment_type":[],"resource_treatment_status":[],"class_list":["post-11541","cri_events","type-cri_events","status-publish","has-post-thumbnail","hentry","events_categories-seminarios-web"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD<\/title>\n<meta name=\"description\" content=\"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0\" \/>\n<meta property=\"og:description\" content=\"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry\" \/>\n<meta property=\"og:site_name\" content=\"Cancer Research Institute\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-20T19:39:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a7bb302f-fd87-410e-87f8-a420c68e14ce.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0\" \/>\n<meta name=\"twitter:description\" content=\"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a7bb302f-fd87-410e-87f8-a420c68e14ce.jpg\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry\",\"url\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry\",\"name\":\"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\",\"isPartOf\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg\",\"datePublished\":\"2022-07-02T00:44:12+00:00\",\"dateModified\":\"2023-04-20T19:39:23+00:00\",\"description\":\"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg\",\"width\":810,\"height\":464},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.cancerresearch.org\/es\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Event\",\"item\":\"https:\/\/www.cancerresearch.org\/events\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cancerresearch.org\/#website\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"name\":\"Cancer Research Institute\",\"description\":\"For a World Immune to Cancer\",\"publisher\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cancerresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cancerresearch.org\/#organization\",\"name\":\"Cancer Research Institute\",\"url\":\"https:\/\/www.cancerresearch.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"contentUrl\":\"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg\",\"width\":156,\"height\":53,\"caption\":\"Cancer Research Institute\"},\"image\":{\"@id\":\"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD","description":"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry","og_locale":"es_ES","og_type":"article","og_title":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0","og_description":"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.","og_url":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry","og_site_name":"Cancer Research Institute","article_modified_time":"2023-04-20T19:39:23+00:00","og_image":[{"url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a7bb302f-fd87-410e-87f8-a420c68e14ce.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0","twitter_description":"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.","twitter_image":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/06\/a7bb302f-fd87-410e-87f8-a420c68e14ce.jpg","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry","url":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry","name":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD","isPartOf":{"@id":"https:\/\/www.cancerresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage"},"image":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage"},"thumbnailUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg","datePublished":"2022-07-02T00:44:12+00:00","dateModified":"2023-04-20T19:39:23+00:00","description":"The past year saw a number of advances in cancer immunotherapy, whose implication for current patient care will be discussed.","breadcrumb":{"@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#primaryimage","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2022\/07\/CRI-web-banner-810x464-1.42.jpg","width":810,"height":464},{"@type":"BreadcrumbList","@id":"https:\/\/www.cancerresearch.org\/events\/cancer-immunotherapy-2022-research-john-wherry#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.cancerresearch.org\/es"},{"@type":"ListItem","position":2,"name":"Event","item":"https:\/\/www.cancerresearch.org\/events"},{"@type":"ListItem","position":3,"name":"Cancer Immunotherapy: 2022 Research and a Look Ahead with E. John Wherry, PhD\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.cancerresearch.org\/#website","url":"https:\/\/www.cancerresearch.org\/","name":"Cancer Research Institute","description":"For a World Immune to Cancer","publisher":{"@id":"https:\/\/www.cancerresearch.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cancerresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cancerresearch.org\/#organization","name":"Cancer Research Institute","url":"https:\/\/www.cancerresearch.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","contentUrl":"https:\/\/www.cancerresearch.org\/wp-content\/uploads\/2025\/05\/logo-gradient.svg","width":156,"height":53,"caption":"Cancer Research Institute"},"image":{"@id":"https:\/\/www.cancerresearch.org\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events\/11541","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/cri_events"}],"about":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/types\/cri_events"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media\/27531"}],"wp:attachment":[{"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/media?parent=11541"}],"wp:term":[{"taxonomy":"events_categories","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/events_categories?post=11541"},{"taxonomy":"resource_cancer_types","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_types?post=11541"},{"taxonomy":"resource_patient_age","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_patient_age?post=11541"},{"taxonomy":"resource_cancer_stage","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_cancer_stage?post=11541"},{"taxonomy":"resource_treatment_type","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_type?post=11541"},{"taxonomy":"resource_treatment_status","embeddable":true,"href":"https:\/\/www.cancerresearch.org\/es\/wp-json\/wp\/v2\/resource_treatment_status?post=11541"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}